Aggregation of the intrinsically disordered protein alpha-Synuclein (α-Syn) into insoluble fibrils with a cross-β sheet amyloid structure plays a key role in the neuronal pathology of Parkinson's disease (PD). The fibrillation pathway of α-Syn encompasses a multitude of transient oligomeric forms differing in size, secondary structure, hydrophobic exposure and toxicity. According to a recent solid state NMR study, the fibrillating unit of α-Syn contains the core residues of the protein arranged into in-register parallel β sheets with a unique Greek key topology. Here, we have shown that the physiologically available small molecule heme (hemin chloride) when added at sub-stoichiometric ratios to either monomeric or aggregated α-Syn, arrests its aggregation in an oligomeric state, which is minimally toxic. Using cryo-EM, we observed that these heme-induced oligomers are 'mace'-shaped and consist of approximately four monomers. However, the presence of a crucial twist or contortion in their Greek key structural architecture prevents further hierarchical appending into annular oligomers and protofilament formation. We confirm using a His50Gln mutant that the binding of heme onto His50 is crucial in inflicting the structural distortion and is responsible for the stabilization of the non-toxic and off-pathway α-Syn oligomers. We believe that this study provides a novel strategy of developing a therapeutic solution of PD, which has been elusive so far.
Introduction
A plethora of evidences associate the fibrillation of the intrinsically unfolded protein alpha synuclein (α-Syn) with the neurodegenerative movement disorder Parkinson's disease (PD) (1, 2). PD is characterised by the presence of fibrillar intracellular Lewy body plaques within the dopaminergic neurons of the substantia nigra of the mid-brain. In vitro, α-Syn has been shown to follow the nucleation-conversion-polymerization model of aggregation (3, 4) . The kinetics of this pathway initiates with the primary nucleation phase, in which the native monomeric protein misfolds to form nuclei which combine and subsequently elongate to give rise to different classes of oligomers, protofilaments and fibrils. Current hypotheses predict that the initial oligomeric intermediates of fibrillar structures, common to many neurodegenerative disease-related proteins including α-Syn, are the primary toxic species.
Upon maturation, the fibrils which are otherwise minimally toxic (5) , fragment into oligomers which act as secondary nuclei or 'seeds' for de novo fibrillation giving rise to a feedback loop of fibril amplification (6) .
Several structural descriptions of mature fibrillar assemblies manifest the universality of the amyloid cross-β architecture (7) . A solid state NMR study has revealed a 'Greek-key' β-sheet topology of a fibrillar assembly of α-Syn monomers (8) , which also coincides with the conserved 'bent β arch kernel' architecture of both the rod and twister fibril polymorphs observed recently (9) . Although 3D architectures of α-Syn fibril assembly determined by high-resolution cryo-EM, have been published very recently (9) (10) (11) , structural understanding of the intermediate species which precedes fibrillation is limited. Some structural evidences of oligomeric structures describe annular intermediates with a central pore, which might explain the characteristic pore-forming activity (12) of α-Syn protofibrils during membrane permeabilization (6, 13) . A more recent study has identified lipid binding structural elements at the N-terminal of a specific oligomeric species of α-syn that are responsible for cell disruption and consequently give rise to cellular toxicity (14) . As a result, structural insights into the heterogeneous classes of oligomers formed in the early stages of the aggregation pathway of α-syn have been deemed as necessary in order to design potential therapeutic strategies against PD.
Heme has been reported to interact with α-Syn leading to the formation of soluble oligomers (15) , suggesting that this may be the mechanism by which filament formation is inhibited.
Additionally, ferric dehydroporphyrin IX and related macrocyclic compounds can inhibit amyloid fibril formation with IC50 values in the low micromolar range (16) (17) (18) . Under physiological conditions within the human brain and peripheral RBCs, the heme-containing neuronal hemoglobin scavenges α-Syn, leading to a reduction of PD-induced mitochondrial damage and apoptosis (19) . Additionally, over-expression of heme-containing neuroglobin inside neuronal cells, which also express α-Syn, reduces cytoplasmic α-Syn inclusions and associated mitochondrial damage (20) . These results encouraged us to obtain a deeper insight into the mechanism underlying the prevention of fibrillation of α-Syn upon the addition of heme.
The addition of heme (in the form of hemin chloride) to either monomeric α-Syn (at 0 h, preincubation) as well as to a heterogeneous population of prefibrillar and fibrillar aggregates (after 48 h of aggregation, late incubation) at a sub-stoichiometric molar ratio yielded small morphologically similar oligomeric structures, suggesting that these structures are the stable endpoints of the heme-induced inhibition of aggregation. We employed cryo-electron microscopy (cryo-EM) for the structural characterization of these similar-sized heme-treated oligomeric forms which revealed that heme primarily stabilizes a 'mace'-shaped oligomer comprising approximately four monomers. This structure is presumed to be the fundamental unit of the fibrillar aggregates of α-Syn as it closely resembles the recently proposed solid state NMR-based 'Greek key' model of the elementary unit of a protofilament of α-Syn (8, 9) . Nevertheless, closer analysis of the molecular architecture of the heme-stabilized mace oligomer indicated that the structure represents a distorted version of the Greek key. We therefore termed the heme-treated oligomer with the distorted Greek key motif as the 'twisted Greek key oligomer' (8, 9) .
Recent advances in the 3D structure elucidation of the fibrils of α-Syn using cryo-EM have demonstrated that the monomeric units folded into the Greek key motif stack upon each other with their longitudinal axes parallel to each other, to form a protofilament. Two such protofilaments intertwine down the length of their longitudinal axes along a tightly packed steric zipper interface to form either the mature rod-like or twister-like fibril polymorphs (9) .
The conformational distortion in the twisted Greek key oligomers occurs upon heme binding to the His50 residue of α-Syn located at (rod polymorph) or near (twister polymorph) the inter-protofilament hydrophobic steric zipper interface, which weakens/ prevents the binding between the two protofilaments, thereby disintegrating the fibril (9) . The role of His50 was confirmed by employing a His50Gln (H50Q) mutant, which did not offer heme-induced inhibition of aggregation. Additionally, using FT-IR, we observed a reduction in the antiparallel β sheet component of the oligomers that were treated with heme. In accordance to previous reports (18, 21, 22) , this finding can be correlated with the toxicity of the hemetreated twisted Greek key oligomeric population that showed reduced transcellular seeding propensity as well as low pathogenicity to both biomembrane-mimicking liposomes and neuroblastoma cells, as compared to the on-pathway fibril-forming oligomers. Our results have allowed us to propose the molecular mechanism of heme-mediated inhibition of α-Syn fibrillation. The identification and characterization of the twisted Greek key oligomer as the fundamental unit of α-Syn amyloid assembly provides insights into the mechanism of fibril formation and sheds light on opportunities for therapeutic intervention at various stages of aberrant protein self-assembly.
Results and Discussion
Heme inhibits the primary and secondary nucleation micro-events within the fibrillation pathway of α-Syn
We used Thioflavin T (ThT) fluorescence to investigate the effect of heme on the different microscopic events that occur within the amyloid assembly process of α-Syn.
In the absence of heme, we observed the distinctive sigmoidal aggregation kinetics (23, 24) of α-Syn ( Figure 1A ). The ThT data was complimented by direct imaging by negative stain TEM and AFM, which clearly showed the formation of a fibrillar network of α-Syn ( Figure 1B ). The diameter of the mature fibrils after 96 hours of incubation in the absence of heme typically varied between 8.5-10 nm (TEM data, Figure 1B ), while the mean height measured 9.7 nm (AFM data, Figure 1B ). The length of the fibrils measured between 0.5-2 μm. Upon addition of heme at the beginning of the aggregation reaction (pre-incubation; α-Syn/heme 25:1), the protein showed insignificant ThT fluorescence, indicating the heme-induced inhibition of the primary nucleation-elongation micro-events in a dose-dependent manner ( Figure 1A ). This was supported by the TEM and AFM results which showed that upon preincubation with heme, fibril formation did not occur even after 96 hours of incubation under aggregation-inducing conditions ( Figure 1C) . Instead, the aggregation was stopped at the oligomer stage, the diameters of which varied between 1 and 3.5 nm, while the mean height according to AFM measurements was 2.3 nm ( Figure 1C ).
These oligomers formed when α-Syn is treated with heme from the beginning of the aggregation period have been named oligomers1 in this study.
In contrast to the usual sigmoidal behaviour, the presence of pre-existing fibril seeds resulted in hyperbolic aggregation kinetics ( Figure 1D ). However, seeds prepared from fibrils that had been incubated in presence of heme appeared to be inert and completely inhibited seed-induced aggregation ( Figure 1D ). We subsequently investigated the effect of heme on the processes of fibril fragmentation and secondary nucleation within the amyloid amplification cycle. When heme was added to the fibrillar aggregates that are formed after 96 h of incubation under aggregationinducing conditions, (α-Syn/heme 25:1, late incubation) it caused a dose-dependent and stable reduction in ThT fluorescence ( Figure 1E ), suggesting the inhibition of secondary nucleation on preformed fibril surfaces. The TEM image ( Figure 1F) depicting the breakdown of the 96 h aggregates showed an aggresome that predominantly comprised a homogeneous population of spherical oligomers upon incubation with heme (α-Syn/heme 25:1). The mean height of 2.7 nm of these oligomers was calculated from the corresponding AFM image ( Figure 1F ).
Collectively, these results demonstrate that heme can arrest the multi-pathway fibrillation processes and convert the heterogeneous aggresome into a population of predominant oligomeric species, which shall be henceforth termed as oligomers2.
Heme reduces seeding capacity and toxicity of α-Syn oligomers1 and oligomers2
Within the brain of patients suffering from PD, the on-pathway α-Syn aggregates spread transcellularly along neural networks and seed de novo aggregation via prion-like mechanisms (25, 26) . To demonstrate the off-pathway (i.e. non-fibril forming) non-seeding nature of the heme-stabilised oligomers, in vitro seeding of exogenously-added heme-treated as well as untreated fibril seeds was studied in SH-SY5Y cells that were transiently transfected with an EGFP-α-Syn construct. Figure 2A shows the confocal image of cells transfected with the GFP construct that were subsequently transduced with 1 μM sonicated fibril seeds for 24 h. At this concentration, the majority of cells displayed punctate intracellular inclusions. Importantly, cells treated with fibrils prepared in presence of heme ( Figure 2B ) or those transfected with α-Syn-GFP but not transduced with any seeds (vehicle, Figure 2C ) did not convert to an inclusion-positive state.
Subsequently, we compared the toxicity of the various structural forms of the protein that are formed during the aggregation pathway in the absence and presence of heme. For this purpose, we collected aliquots from the aggregation reaction of the protein after every 12 hours. In the first assay, the species formed in the absence (on-pathway oligomers, Figure   2D ) and presence of heme ( Figure 2E : oligomers1, pre-incubation; 2F: oligomers2, late incubation) were treated with calcein-loaded 3: 7 POPC: DOPS small unilamellar vesicles (SUVs) at a protein: lipid ratio of 1:10. Pore formation induced by the different structural forms of α-Syn lead to permeable vesicles releasing calcein, the extent of which indicated the toxicity of that particular protein form. Additionally, we quantified the percentage of SH-SY5Y neurobastoma cells undergoing early and late apoptosis/ necrosis in presence of the heme-treated or untreated structural species of α-Syn. In accordance to previous reports (13), we observed that the heterogeneous population of oligomers, protofilaments and protofibrils, (these structures were observed from AFM measurements, Figure S1A , SI) formed between 24 h and 48 h of incubation induce maximum toxicity in both SUV membranes as well as neuroblastoma cells. The heme-stabilised structures (pre-incubation with heme: oligomers1 or late incubation with heme: oligomers2) at the equivalent time-points showed significantly reduced toxicity ( Figure 2E and 2F, respectively).
Structural characterization of the heme-stabilized oligomers
A previous study (13) has described using cryo-EM that the fibril-forming on-pathway oligomers formed after 20-24 h of aggregation are annular. These oligomers possess a high content of anti-parallel β sheets and show liposomal permeability as well as cytoxicity. In order to study the mechanism of heme-induced prevention of fibrillation of α-Syn, we prepared these on-pathway oligomers and compared their structure with that of the heme-preincubated oligomers1 that were formed by incubating the monomeric protein with heme (α-Syn/Heme 25:1) under aggregation-inducing conditions for 24 h. Additionally, we also studied the structure of the oligomers2 that were formed when the heterogeneous aggresome formed after 48 h of aggregation was treated with heme (late incubation).
Using FPLC-size exclusion chromatography, we isolated the oligomers1 and oligomers2, both of which eluted at an identical retention time of 17.1 minutes. This proves that the addition of heme for both pre-incubation or late incubation conditions populates oligomers of identical molecular weight/ size ( Figure S1B , SI). FT-IR measurements were then used to compare the secondary structures (27) of the untreated on-pathway oligomers with the purified heme treated oligomers1 and oligomers2. The on-pathway oligomers formed after 24 h of incubation in the absence of heme that showed augmented toxicity, contained a large extent (12%) of antiparallel β sheet structure ( Figure 3A ) evidenced by component bands at ~1685-95 cm -1 along with four times prominent bands at 1620-38 cm -1 , in accordance with previous studies (13) . In contrast, the oligomers1 ( Figure 3B ) and oligomers2 ( Figure 3C ) contained a much reduced antiparallel β sheet component (~2%). Similar β sheet orientation in the oligomeric species of α-Syn have been reported previously (28) , and oligomer populations with differing characteristics have been shown to cause difference in the membrane perturbation and cell death via apoptosis (18, 21, 22) . The low frequency bands at ~1617 cm -1 are associated with β-strands in aggregated structures indicating inter-molecular β sheet structure with strong hydrogen bonds.
Subsequently, we used cryo-EM in conjunction with single particle reconstruction technique The cryo-EM micrographs of dataset 2 in contrast, showed an ensemble of particles of different sizes along with few short length fibrillar structures ( Figure 4D ). We selected the population of oligomers (oligomers2) that appeared qualitatively similar in size to the particles seen for oligomers1 (~6-8 nm; Figure 4D ). These small size particles were selectively picked, following which three reference-free 2D analyses were done ( Figure 4E ), and a 3D cryo-EM map was generated following the same procedure used for oligomers1
( Figure 4F ). Both the 3D cryo-EM maps ( Figure 4C and 4F) appeared as a club with a heavy head ('mace oligomer'). The resolutions of the maps generated from dataset 1 and dataset 2 were estimated to be ~12.6 Å and 12 Å, respectively, as determined by the 0.5 FSC criterion ( Figure S2A and S2C).
Thus, it is evident that the mace oligomer is the fundamental structural unit formed whenever heme is added to α-Syn at any stage (early or late) in its aggregation pathway. Earlier literatures have reported α-Syn oligomers to be annular in shape of different dimensions (13, 32) . We have also identified the formation of a horseshoe-shaped oligomer when α-Syn was allowed to aggregate for 20-24 h in the absence of heme ( Figure S2 , S3) which appeared to be a precursor of the annular forms ( Figure S3C ). Interestingly, the presence of mace-like units could be detected within the structure of the on-pathway horseshoe oligomer formed in the absence of heme ( Figure S3D , E), indicating that the mace-like units probably assemble to form the annular oligomers. We propose that the individual mace oligomers are unstable and hence immediately assemble to form higher order annular structures. However, heme stabilizes the mace oligomers and also disintegrates the annular forms (or protofibrils/ mature fibrils) into their constituent mace oligomers.
Heme stabilizes the 'molecular mace' architecture by interacting with His50:
Our results suggest that the assembly of more than one mace oligomers of α-Syn leads to the formation of an annular oligomer. However, heme stabilizes the mace oligomer in such a manner that its propagation into higher order oligomers and fibrillar structures is terminated.
In order to comprehend the molecular mechanism underlying the stabilization of the mace oligomers by heme, we measured the binding affinity of heme to the tetramethylrhodamine-5-maleimide (TMR)-tagged monomeric α-Syn Gly132Cys (G132C) mutant, by studying the heme-induced quenching of the dye. Since wild type α-Syn does not have a cysteine residue, a G132C mutation was introduced for the maleimide labelling. This single cysteine mutant G132C is considered similar to the wild type protein for biophysical studies (23, 33) . While the dissociation constant (Kd) and number of binding sites on the α-Syn G132C monomer for heme was 590 nM and 1 respectively ( Figure 5A ), heme binding to α-Syn was not observed when excess (10 mM) imidazole was present ( Figure S4A , SI), suggesting a probable binding of the heme to a histidine residue in the protein.
The heme-α-Syn WT complex was also found to have a considerably high peroxidase (Hiscoordinated heme enzyme) activity (34) compared to hemin chloride ( Figure 5B ). These experiments further indicated the involvement of His residues in the heme-α-Syn binding. A molecular modelling exercise of the heme-induced mace oligomer structure suggested His50, Tyr39, Tyr125, Tyr133 and Tyr136 as five potential residues, which are present on the solvent-exposed surface of the mace structure and could be involved in the oligomeroligomer or oligomer-heme stabilization ( Figure 5C ). Since His50 is the only histidine positioned at this region, we prepared a His50Gln (H50Q) mutant. Although H50Q aggregated to an extent similar to the WT protein, its aggregation was not inhibited by the addition of heme (Figure 5D : ThT; 5E: AFM). Moreover, the H50Q mutant did not show any binding to heme as observed from the fluorescence binding measurement ( Figure 5F ) and had no peroxidase activity in presence of heme either ( Figure 5B ). These results confirmed the crucial role of His50 in the heme-mediated stabilization of the mace structure. Incidentally, H50Q is a missense mutation that causes a late-onset familial form of PD and dementia (35) .
We propose that the absence in this mutant, of the only His residue that can bind to the physiologically-prevalent heme and thus salvage fibrillation is responsible for its susceptibility to aggregation.
As mentioned previously, a recent NMR study identified a unique conformation of an oligomeric unit (9) (comprising ten monomers) of the α-Syn fibril with a Greek-key motif (8) . More recently, cryo-EM studies revealed similar Greek-key folds / 'kernels' in α-Syn fibrils (9, 10). Our oligomers1 and oligomers2 had a SEC retention time of 17.1 minutes that correspond to a MW of ~65 kDa ( Figure S1C ), providing preliminary evidence that these oligomers contain approximately 4 monomeric units (MW of monomeric α-Syn 14.5 kDa).
Both oligomers1 oligomers2 show striking resemblances with the recently described Greekkey structural motif consisting of ~ four monomers ( Figure 6A ) (36) . The Greek-key architecture fits well in the C-terminal or head region of the molecular mace structure.
However, a distortion was observed at the junction of the head and the base of the hemestabilized mace oligomer giving rise to the 'twisted Greek key oligomer' (Figure 6B-C).
Segmentation (in Chimera) of the horseshoe-shaped oligomeric intermediate formed in the absence of heme resulted in three segments of similar shape and size. Interestingly, a tetrameric unit of α-Syn with the Greek key motif could be accommodated well into each of the segments in Chimera ( Figure S3D , E). Thus, apparently, tetrameric units containing the Greek key motif are initially formed which subsequently self-assemble to form annular structures of different dimensions. We hypothesize that heme binding to the His50 residues on the exposed surface of the tetrameric Greek key structure either at (rod fibril polymorph)
or near (twister polymorph) the head-base junction ( Figure 7 ) induces a torsion ( Figure 4C and 4F) and thereby dislodges further amyloid assembly.
Thus, our structural analyses along with biochemical results suggested that α-Syn oligomerization proceeds via beta-stacked structure containing the Greek key motif as proposed by Tuttle et al (8) . Upon heme treatment, either during progression of fibrillation or degradation of mature fibrillar structures, heme prefers to bind to an oligomeric form comprising ~4 associated monomers. Heme binding distorts this structure into a 'twisted Greek key' resulting in an inert 'off pathway' oligomer that shows reduced cytotoxicity. As a consequence of this distortion, further association of monomers to form mature amyloid fibrils is inhibited ( Figure 7 ).
Conclusion
By studying the mechanism of heme-induced fibril breakdown, we propose the probable hierarchical fibril construction machinery of α-Syn. Figure 7C ) and the twister fibril polymorphs ( Figure 7C) showing the location of the heme-binding His50 residue. However, the amalgamation of the Greek key oligomers into either annular oligomers or elongated protofibrils is halted in the presence of heme through one of the following two pathways. In the first pathway, heme binding to the His50 residues of the Greek key oligomer causes a torsion at its head-neck interface ( Figure 7D ) leading to the formation of the twisted Greek key oligomer. This arrests further association into either annular oligomers or protofibrils. In the second mechanism, preformed annular oligomers and protofilaments break down into the twisted version of the Greek key oligomer upon heme-binding, thereby compromising the binding interfaces and preventing further fibrillation ( Figure 7D ).
The second mode of heme-mediated inhibition of fibrillation involves the hydrophobic preNAC steric zipper geometry (i.e., residues Gly51-Ala56) of the fibril rod polymorph. The protofilament interface is stabilized by a salt bridge between His50 and Glu57 (Glu57 belongs to the opposite protofilament). We propose that the heme competes with Glu57 in binding to the His50 residue, thus destabilizing the zipper interface and disintegrating the fibril into its two constituent protofilaments. Stabilization of such a non-toxic off-pathway oligomeric form of α-Syn would be a potential pharmacological approach for PD treatment.
Materials and Methods
For the purification of α-Syn, Tris salt, isopropyl β-D-galactopyranoside (IPTG), 
Expression and purification of α-Syn protein
Recombinant human α-Syn wild type (WT), G132C and H50Q/G132C mutants were expressed in Escherichia coli BL21 (DE3) strain transformed with the pRK172 α-Syn wild type or mutant plasmid. All site-directed mutagenesis were performed using the Agilent Quikchange Lightning site-directed mutagenesis kit (Agilent Technologies, CA, USA). The expression was induced by adding 1 mM IPTG to a culture that had reached an OD of 0.5−0.6. The cultures were then incubated at 37 °C with shaking at 180 rpm for 4 hours. Cells were harvested by centrifugation. The cell pellets were then resuspended in sonication buffer (10 mM Tris, pH 7.4 and 1 mM PMSF) and lysed by sonication using short but continuous pulses at 12 Hz for 1 min. This step was repeated 14 times to lyse all the cells. The lysate was centrifuged at 14000 rpm for 45 min at 4 °C to remove cell debris. The lysis suspension was brought to 30% saturation with ammonium sulfate and the pellet was discarded. This was followed by 50% saturation with ammonium sulfate. The solution was then centrifuged at 20000 rpm for 1 hour at 4 °C. The resultant pellet was dissolved in 10 mM Tris buffer, pH 7.4 and dialyzed overnight against the same buffer. After dialysis, the protein sample was filtered using a 30 kDa centricon filter (Merck Millipore, Darmstadt, Germany). The crude protein was then injected into a DEAE anion exchange column equilibrated with 10 mM Tris (pH 7.4) and eluted using a NaCl gradient. α-Syn was found to be eluted at about 300 mM NaCl. Fractions containing α-Syn (analyzed by Coomassie-stained SDS PAGE) were concentrated and further purified using a Sephadex gel filtration column. Fractions containing purified α-Syn were combined and lyophilized. The protein was determined to be about 95% pure by SDS-PAGE. For the sample preparations of all experiments, lyophilized protein was dissolved in sodium phosphate buffer (pH 7.4) and filtered using 0.22 μm low protein binding membranes (Millex-GP, Merck Millipore, Germany). The protein concentration was determined by the measurement of absorbance at 277 nm using the extinction coefficient 5960 cm
Preparation of heme-treated oligomers1, oligomers2, untreated on-pathway oligomers and preformed seeds
For the preparation of the oligomers1 for cryo-EM, 200 μM lyophilized monomeric α-Syn was dissolved in sodium phosphate buffer, pH 7.4, and incubated for 20-24 h at 37 ºC with constant agitation in the presence of 8 μM hemin chloride (pre-incubation).
For the preparation of the untreated on-pathway oligomers, 200 μM monomeric α-Syn was incubated at 37 ⁰C without agitation for 20-24 hours, after which it was ultracentrifuged at 45,000 rpm for 2 h and the supernatant was collected carefully while fibrils accumulated in the pellet were discarded. The excess monomeric species was removed by multiple filtration using a 100 kDa cutoff centricon (Amicon, Merck Lipofectamine with 2 μM fibril seeds dissolved in OptiMEM for 24 hours, after which they were washed twice with Dulbecco's phosphate buffered saline (DPBS) and subjected to confocal imaging. α-Syn fibril seeds were prepared from the recombinant protein subjected to 96 h of aggregation, after which it was sonicated in a water bath for 15 minutes.
Confocal Microscopy
These experiments were carried out using a Zeiss LSM 510 Meta confocal microscope equipped with a C-Apochromat 40 X (NA=1.20, water immersion) objective and confocal images were acquired with 512 x 512 (pinhole aperture ~ 1 airy units). The α-Syn EGFP protein was excited using an argon laser at 488 nm.
Preparation of SUVs (small unilamellar vesicles)
Monomeric FITC-conjugated Annexin V is a strong probe for the exposed PS and can thus be used for detecting early apoptosis in stressed cells. (43) For the determination of late apoptosis and/or necrosis as a result of oligomer treatment, propidium iodide (PI) was added to the treated cells at a concentration of 2 μg/mL. PI labels the cellular DNA in late apoptotic/ necrotic cells where the cell membrane has been totally compromised.
FTIR Analysis
FTIR measurements of the protein samples were performed in D2O-containing sodium phosphate buffer, pH 7.5 on a Bruker FTIR TENSOR 27 spectrometer. In anti-parallel β-sheet structures, the amide I region displays two typical components:
the major low frequency one has an average wavenumber located at ~1620-1638 cm -1 , whereas the minor high frequency component, 4-5-fold weaker than the major one, is characterized by an average wavenumber at 1695 cm 
Hemin-α-Syn Binding
In order to study the binding of hemin to α-Syn, we incorporated a single cysteine mutation at the C-terminal of α-Syn to which a maleimide-containing dye could be 
where, Ka refers to the association constant. The dissociation constant Kd = 1/ Ka.
Determination of Peroxidase Activity
For the estimation of the peroxidase activity of α-Syn in the absence and presence of heme, 2 μM heme-bound or unbound α-Syn (WT or H50Q, α-Syn/hemin 25:1) was treated at 25ºC with 200 µM H2O2 and 10 mM guaiacol. The product formation kinetics was followed using a Shimadzu 1700 Pharmaspec UV-VIS spectrophotometer. The rate of decomposition of hydrogen peroxide (H2O2) by peroxidase using guaiacol as a hydrogen donor, was determined by measuring the rate of color development spectrophotometrically at 470 nm using the extinction coefficient of 2.66X10 4 M -1 cm -1 (47) .
FPLC-SEC
The FPLC-size exclusion chromatography analysis was performed by injecting samples of heme-treated oligomers1 and oligomers2 onto a Bio-Rad ENrich SEC70 10 x 300 mm column using the Bio-Rad NGC FPLC system (Bio-Rad, CA, USA). The retention time of both oligomer types was compared with a set of molecular weight protein standards (Bio-Rad)
consisting of bovine serum albumin (66.5 kDa), ovalbumin (44 kDa), myoglobin (17 kDa) and vitamin B12 (1.35 kDa). All FPLC runs were performed in pH 7.4 sodium phosphate buffer at a flow rate of 0.5 ml/min and monitored by absorbance at 280 nm.
Cryo-electron microscopy:
Samples (~5 µl) were applied on glow-discharged lacey grids (Ted Pella, CA, USA), followed by blotting and vitrification of the grids using Vitrobot™ (FEI, OR, USA) (48) .
Image data collection was performed on a Tecnai POLARA microscope (FEI, OR, USA) equipped with a FEG (Field Emission Gun) operating at 300 kV. Images were collected with 4K Χ 4K 'Eagle' charge-coupled device (CCD) camera (FEI, OR, USA) at ~79000X magnification (with defocus values ranging from ~1 to 5 μm), resulting in a pixel size of 1.89 Å at the object scale. All images were acquired using low-dose procedures with an estimated dose of ~20 electrons per Å 2 (49) . Micrograph screening and particle picking were done separately using EMAN2 (30) and SPIDER (50) . 60 micrographs for Sample 1 (α-Syn preincubated with heme for 24 h), 41 micrographs for Sample 2 (α-Syn late-incubated with heme after 48 h of aggregation), and 118 micrographs for Sample 3 (α-Syn incubated without heme for 24 h) were selected for particle picking. The initial models for the three different samples were developed using EMAN2.
Validation of the 3D models was done in multiple ways. Particles formed following heme treatment appeared to be very small (~5-8 nm). We imaged three sets of data for each of the samples (each prepared and imaged on different dates) to confirm the sizes of the particles, particularly for oligomers pre-incubated with heme (sample 1), which showed distribution of particles of small sizes. The different views of the reference-free 2D class averages generated by different image processing softwares, e.g., EMAN2, Xmipp (51), RELION (52) as well as reference-based SPIDER were very similar. The initial models generated in EMAN2 were used as references for SPIDER auto picking after which 17831, 18626 and 11515 good particles were selected manually from auto-picked particles of Samples 1, 2 and 3, respectively. The 3D reconstruction was then performed following the standard SPIDER protocol for reference-based reconstruction (50) for each dataset. The 2D re-projections of 3D maps were consistent with the 2D class averages. The overall resolution of three maps generated for samples 1, 2, and 3 were 12.6 Å, 12.0 Å and 16.0 Å, respectively, using the FSC 0.5 cutoff criteria (8.9 Å, 8.9 Å and 11.0 Å using the 0.143 cutoff criteria, Figure S2 ).
We also manually produced another starting model from the Greek key structural motif (as a tetramer) by low pass filtering. The density model showed no distortion at the head and base junction. 2D back projections of this 3D structure also resembled 2D class averages of samples 1 and 2 ( Figure S2 ). Final 3D map generated from dataset of sample 1 (oligomers1) using this initial model showed similar 'molecular mace' architecture with a twist at the head and base junction.
Surface rendering, docking of crystal structures, segmentation and analyses of the 3D maps were performed in the program UCSF Chimera (53), Pymol (54) , and VMD (55) .
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